Weightwatchers International Inc.

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: North America, United Kingdom, Continental Europe and Other. The North America segment consists of United States and Canada company-owned operations. The United Kingdom segment includes United Kingdom company-owned operations. The Continental Europe segment consists of Germany, Switzerland, France, Spain, Belgium, Netherlands, and Sweden company-owned operations. The others segment offers Australia, New Zealand company-owned operations, as well as revenues and costs from franchises in the United States. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Weight Watchers to Lead Clinical Weight Management with Strategic Acquisitions

Weight Watchers International is confident in its ability to return to a growth trajectory by providing science-based solutions for weight management. The company's strategic acquisitions, enhanced marketing approach, and product enhancements position it well for future success in the weight management industry.

Weight Watchers beats Q1 targets, eyes growth through digital

Weight Watchers International's Q1 2023 performance exceeded expectations with strong subscriber growth and revenue results.
The company's focus on digital expansion, data-informed culture, and strategic acquisitions positions it well for future growth.
Challenges include intensifying competition, sustaining growth amidst lower marketing spend, and successful integration of acquisitions.
Opportunities lie in enhancing member experience, expanding in the clinical space, and leveraging brand equity for efficient growth.

WeightWatchers reports subscriber growth despite revenue challenges and supply shortages

WeightWatchers International is navigating challenges in revenue due to clinical supply shortages but is focusing on core business growth and member engagement. The company's strategic focus on weight health leadership and synergies between its core and clinical businesses present opportunities for growth and innovation.

Weight Watchers reports strong Q3 performance, eyes growth opportunities

Weight Watchers International (WW) delivered a strong performance in Q3, with notable subscriber growth, revenue, and margin expansion. The company's strategic focus on innovation, partnerships, and cost efficiency underpins its resilience and market competitiveness.
While facing challenges such as supply constraints and uncertainties in future guidance, Weight Watchers remains committed to sustainable growth through subscriber-centric strategies and operational agility. Opportunities lie in expanding Clinical offerings, targeted programs, and industry engagement.
Overall, Weight Watchers' Q3 earnings call highlights its financial strength, strategic direction, and commitment to driving subscriber growth and engagement. The company's performance underscores its ability to adapt, innovate, and navigate challenges in the competitive landscape.

Weight Watchers focuses on health, sees growth in subscribers

Weight Watchers International Inc. is prioritizing growth in clinical subscribers and subscription revenue, focusing on enhancing digital products, and differentiating itself through science and brand equity. The company is confident in delivering year-over-year growth in various key metrics for 2024.

WeightWatchers International Inc. reports strong Q1 performance and strategic growth initiatives

WeightWatchers International Inc. delivered a strong performance in Q1 2024, showcasing growth in clinical business, record margins, and strategic initiatives to drive long-term growth. While facing challenges in marketing strategy shifts and restructuring costs, the company is well-positioned to capitalize on opportunities in subscriber ARPU stabilization, B2B partnerships, and product enhancements.

WeightWatchers anticipates growth amidst challenges, emphasizes cost-saving measures

WeightWatchers International faces short-term challenges but remains optimistic about its financial performance for the year. The company is implementing cost-saving measures, focusing on strategic growth initiatives, and emphasizing the importance of expanding access and care options.

WeightWatchers reports Q3 revenue decline but focuses on growth

WeightWatchers International is navigating challenges while leveraging strengths to drive growth and operational efficiency.
The company's focus on innovation, brand revitalization, and cost savings aligns with long-term growth objectives.
Despite market dynamics, WeightWatchers remains optimistic about future demand and committed to strategic initiatives for turnaround.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

WW International, Inc. (NASDAQ:WW ) Q3 2024 Results Conference Call November 6, 2024 8:30 AM ET Company Participants David Helderman - Vice President, Investor Relations Tara Comonte - Interim President & Chief Executive Officer Heather Stark - Chief Financial Officer Donna Boyer - Chief Product Officer Conference Call Participants Nathan Feather - Morgan Stanley Alex Fuhrman - Craig-Hallum Capital Group Karru Martinson - Jefferies Henry Carr - UBS Operator Good day, and welcome to the WW International Third Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.

WW International, Inc. (WW) Q3 2024 Earnings Call Transcript

WW International (WW) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.

WW International (WW) Beats Q3 Earnings and Revenue Estimates

NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wednesday, November 6, 2024.

WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call

WeightWatchers announced on Tuesday that it will offer a compounded version of Novo Nordisk‘s popular weight-loss drug Wegovy as part of its weight-management programs, a move that sent its shares soaring nearly 47%.

WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy

Shares of WW International Inc (WW, Financial) soared by 43.09% today due to the company's strategic move to expand its clinical weight management services. This expansion includes the introduction of compounded semaglutide, which offers a cost-effective and accessible alternative to popular medications like Ozempic and Wegovy, particularly during the current supply shortages.

WW Stock Rises as WeightWatchers Expands Drug Offerings

WW International (WW, Financial) experienced a significant stock price increase, soaring 20.7% to $1.40. Early trading saw the stock rise as much as 46.5%.

WW International (WW) Surges After Adding Semaglutide to Weight Loss Program

WW International (WW, Financial), a provider of weight loss solutions, experienced a significant stock movement with an initial surge of over 46.5%, which later narrowed to around a 25% increase, reaching $1.45. This follows a nearly 47% rise in the previous trading session.

WW International (WW) Surges After Introducing Compounded Semaglutide to Weight Loss Plans

Shares of WW International (WW), better known as WeightWatchers, jumped nearly 25% Tuesday when the dieting services company announced it is offering a copycat version of blockbuster weight-loss drugs.

WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering

“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief Executive Tara Comonte in prepared remarks.

WeightWatchers' stock soars after adding compounded GLP-1 treatment to its offering

WeightWatchers said on Tuesday it is adding a compounded version of Novo Nordisk's obesity drug Wegovy to its weight-management programs.

WeightWatchers adds compounded version of Novo's obesity drug to weight-loss program

WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.

WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy

WeightWatchers CEO Sima Sistani is leaving the company after two and a half years. During that time, the company has radically altered its business model to stay competitive in the Ozempic era.

WeightWatchers CEO Sima Sistani is leaving the company

The executive led the diet company, better known as WeightWatchers, since 2022 into the burgeoning market for obesity drugs.

WW Parts Ways With President, CEO Sima Sistani

Independent Board Member Tara Comonte Will Serve as Interim Chief Executive Officer Sima Sistani Will Step Down as CEO and Director

WeightWatchers Announces Executive Leadership Transition

Additions of Chief Commercial Officer and Chief Impact Officer emphasize the Company's continued focus on growth ahead of 2025 Additions of Chief Commercial Officer and Chief Impact Officer emphasize the Company's continued focus on growth ahead of 2025

WeightWatchers Announces Strategic Leadership Team Appointments

WW International, Inc. stock has lost almost 80% of its value since my previous article in March 2023, which I published soon after the company announced the Sequence acquisition. Expansion into clinical services poses risks of cannibalization and increased competition for WW International's core weight loss business. The strategic shift towards digital subscriptions and clinical services may limit WW International's potential for long-term competitive advantages and growth.

WW International: There May Never Be A Resurrection

WW International, Inc. (NASDAQ:WW ) Q2 2024 Earnings Call August 1, 2024 8:30 AM ET Company Participants Corey Kinger - Vice President, Investor Relations Sima Sistani - Chief Executive Officer Heather Stark - Chief Financial Officer Conference Call Participants Jack Wallace - Guggenheim Securities Henry Carr - UBS Nathan Feather - Morgan Stanley Alex Fuhrman - Craig-Hallum Stephanie Davis - Barclays Karru Martinson - Jefferies Operator Welcome to the WW International's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] I'd now like to turn the call over to your host, Corey Kinger, VP Investor Relations.

WW International, Inc. (WW) Q2 2024 Earnings Call Transcript

WW International (WW) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.04 per share a year ago.

WW International (WW) Reports Q2 Loss, Lags Revenue Estimates

Shares of WW International Inc., formerly known as Weight Watchers, dropped 1.9% into record-low territory, after the weight management company reported disappointing second-quarter results, lowered its full-year outlook and announced a restructuring plan. Net income fell to $23.3 million, or 29 cents a share, from $50.8 million, or 65 cents a share, in the same period a year ago.

WW International's stock falls toward a fresh record low after disappointing results, lowered outlook

NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the second quarter of fiscal 2024.

WW International, Inc. Announces Second Quarter 2024 Results

NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the second quarter 2024 before market open on Thursday, August 1, 2024.

WW International, Inc. Schedules Second Quarter 2024 Earnings Conference Call

Medifast

Pfizer

Novo Nordisk's (NYSE: NVO ) Ozempic diabetes treatment, marketed as a weight loss treatment under the Wegovy brand name, has become the latest mega-blockbuster drug. Yet, while you may be thinking about ways to capitalize on its popularity and the rise of other glucagon-like peptide-1 (GLP-1) weight loss treatments, you should also consider the stocks to sell because of this trend.

3 Stocks to Sell as Ozempic Surges in Popularity

WW International, Inc. (NASDAQ:WW ) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants Corey Kinger - IR Sima Sistani - CEO Heather Stark - CFO Conference Call Participants Jack Wallace - Guggenheim Nathan Feather - Morgan Stanley Linda Bolton - D.A. Davidson Alex Fuhrman - Craig-Hallum Capital Group Stephanie Davis - Barclays Karru Martinson - Jefferies Jack Wallace - Guggenheim Nathan Feather - Morgan Stanley Operator Good day and welcome to the Weight Watchers International's First Quarter 2024 Earnings Conference Call.

WW International, Inc. (WW) Q1 2024 Earnings Call Transcript

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the first quarter of fiscal 2024.

News for Weightwatchers International Inc. Stock (WW)